InflaRx (IFRX) Other Non Operating Income (2017 - 2026)
InflaRx's (IFRX) quarterly Other Non Operating Income came in at $576454.1 in Q1 2026, up 128.71% year-on-year from $252046.1 in Q1 2025, and up 1047.55% quarter-over-quarter from -$60836.4 in Q4 2025.
InflaRx (IFRX) Other Non Operating Income (2017 - 2026) Analysis & Trends
InflaRx has disclosed Other Non Operating Income across 10 years of filings, most recently posting $576454.1 for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $576454.1, up 128.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $571322.8 (up 601.81% YoY), and the FY2025 annual result was -$5.6 million, down 244.01% from the prior year.
- Other Non Operating Income came in at $576454.1 for Q1 2026 at InflaRx, up from -$60836.4 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $889.7 billion in Q3 2022 to a low of -$1220.7 billion in Q1 2023.
- The 5-year median for Other Non Operating Income is $766109.7 (2024), against an average of -$19.5 billion.
- Across the five-year window, Other Non Operating Income surged 105394589.14% in 2022 and tumbled 149417763.85% in 2023, its largest moves.
- InflaRx's Other Non Operating Income stood at -$746398.7 in 2022, then sank by 132.09% to -$1.7 million in 2023, then surged by 345.64% to $4.3 million in 2024, then slumped by 101.43% to -$60836.4 in 2025, then soared by 1047.55% to $576454.1 in 2026.
- The last three Other Non Operating Income figures came in at $576454.1 (Q1 2026), -$60836.4 (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 576,454.08 |
| Dec 31, 2025 | -60,836.41 |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | -3.25 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Jun 30, 2024 | 766,109.67 |
| Mar 31, 2024 | 1.98 Mn |
| Dec 31, 2023 | -1.73 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 835,908.45 |
| Mar 31, 2023 | -1,220.72 Bn |
| Dec 31, 2022 | -746,398.69 |
| Sep 30, 2022 | 889.67 Bn |
| Jun 30, 2022 | 1.67 Mn |
| Mar 31, 2022 | 816,986.66 |
| Dec 31, 2021 | 2,246.91 Bn |
| Sep 30, 2021 | 844,132.69 |
| Jun 30, 2021 | -995,093.10 |